期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment
1
作者 Xiaolan Xu Jiaming Zhang +10 位作者 Tao Wang Jing Li yukang rong Yanfang Wang Chenxia Bai Qing Yan Xiaohua Ran Yingli Wang Tianhong Zhang Jin Sun Qikun Jiang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第4期1542-1559,共18页
The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins.In recent years,toxins have been widely used as warheads for antibody-drug conjugates(ADCs)due to their eff-cient killing activity a... The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins.In recent years,toxins have been widely used as warheads for antibody-drug conjugates(ADCs)due to their eff-cient killing activity against various cancer cells.Although ADCs confer certain targeting properties to the toxins,low drug loading capacity,possible immunogenicity,and other drawbacks also limit the po-tential application of ADCs.Recently,non-ADC delivery strategies for toxins have been extensively investigated.To further understand the application of toxins in anti-tumor,this paper provided an over-view of prodrugs,nanodrug delivery systems,and biomimetic drug delivery systems.In addition,toxins and their combination strategies with other therapies were discussed.Finally,the prospect and challenge of toxins in cancertreatmentwerealso summarized. 展开更多
关键词 TOXINS Non-antibody-drug conjugates Delivery strategies PRODRUGS Nano drug delivery systems Biomimetic drugdelivery systems Combination strategies Cancer treatment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部